We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
-15.04%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$7.93B
AUM Growth
-$2.01B
Cap. Flow
-$404M
Cap. Flow %
-5.09%
Top 10 Hldgs %
39.56%
Holding
93
New
5
Increased
31
Reduced
42
Closed
5

Top Buys

Rank Stock Value
1
IFF icon
International Flavors & Fragrances
IFF
+$174M
2
CSCO icon
Cisco
CSCO
+$79.5M
3
TMO icon
Thermo Fisher Scientific
TMO
+$69.2M
4
DIS icon
Walt Disney
DIS
+$52.7M
5
NEE icon
NextEra Energy
NEE
+$29.1M

Top Sells

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$199M
2
JPM icon
JPMorgan Chase
JPM
+$104M
3
MRK icon
Merck
MRK
+$101M
4
EQIX icon
Equinix
EQIX
+$61M
5
CL icon
Colgate-Palmolive
CL
+$57M

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Financials 14.65%
3 Healthcare 13.45%
4 Industrials 12.04%
5 Communication Services 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
51
Texas Instruments
TXN
$252B
$28.8M 0.36%
187,288
+14,610
+8% +$2.46M
LLY icon
52
Eli Lilly
LLY
$1.02T
$27.2M 0.34%
83,959
-43,795
-34% -$13.1M
UAA icon
53
Under Armour
UAA
$2.84B
$25.9M 0.33%
3,114,916
– –
EW icon
54
Edwards Lifesciences
EW
$49.6B
$24.1M 0.3%
+253,530
New +$26.2M
TTEK icon
55
Tetra Tech
TTEK
$8.49B
$22.3M 0.28%
815,780
+53,820
+7% +$1.48M
PFE icon
56
Pfizer
PFE
$143B
$21.9M 0.28%
417,697
+13,635
+3% +$695K
ZTS icon
57
Zoetis
ZTS
$32.4B
$20.6M 0.26%
119,797
-10,288
-8% -$1.78M
MSCI icon
58
MSCI
MSCI
$41.6B
$18.1M 0.23%
43,915
-285
-0.6% -$124K
ECL icon
59
Ecolab
ECL
$78.1B
$15.2M 0.19%
98,666
-4,892
-5% -$811K
AAPL icon
60
Apple
AAPL
$4.54T
$15.1M 0.19%
110,747
-236,509
-68% -$35.8M
JPM icon
61
JPMorgan Chase
JPM
$935B
$13.7M 0.17%
121,244
-836,403
-87% -$104M
ARE icon
62
Alexandria Real Estate Equities
ARE
$8.97B
$13M 0.16%
89,511
+23,035
+35% +$3.91M
GLD icon
63
SPDR Gold Trust
GLD
$131B
$11.9M 0.15%
70,506
+5,058
+8% +$883K
AGCO icon
64
AGCO
AGCO
$7.4B
$11.8M 0.15%
120,000
-10,000
-8% -$1.25M
LSI
65
DELISTED
Life Storage, Inc.
LSI
$11.1M 0.14%
99,055
+9,158
+10% +$1.13M
CF icon
66
CF Industries
CF
$19.2B
$10.3M 0.13%
120,000
-45,000
-27% -$4.37M
CPT icon
67
Camden Property Trust
CPT
$11B
$10M 0.13%
74,724
-1,068
-1% -$158K
DOC icon
68
Healthpeak Properties
DOC
$15.1B
$9.35M 0.12%
360,714
-6,392
-2% -$194K
MAA icon
69
Mid-America Apartment Communities
MAA
$15.4B
$9.27M 0.12%
53,086
-941
-2% -$175K
HD icon
70
Home Depot
HD
$331B
$9.25M 0.12%
33,742
-89,339
-73% -$26.4M
EQNR icon
71
Equinor
EQNR
$97.7B
$8.55M 0.11%
246,094
+36,615
+17% +$1.31M
EQR icon
72
Equity Residential
EQR
$24.9B
$7.81M 0.1%
108,148
+57,231
+112% +$4.54M
KRC icon
73
Kilroy Realty
KRC
$4.52B
$7.34M 0.09%
140,300
+53,636
+62% +$3.4M
BXP icon
74
Boston Properties
BXP
$11.2B
$7.1M 0.09%
79,788
+6,610
+9% +$732K
MOS icon
75
The Mosaic Company
MOS
$7.03B
$7.08M 0.09%
150,000
– –
1 2
3
4

Similar funds

PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Sarasin & Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Sarasin & Partners held 93 positions worth $7.93B, down 20% from $9.95B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sarasin & Partners withdrew a net $404M in Q2 2022, closing 5 positions and reducing 42 holdings. Its most notable exit was Marriott International, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sarasin & Partners opened a new position in Edwards Lifesciences worth $24.1M.

  • Sarasin & Partners's largest Q2 2022 buy was Edwards Lifesciences: 253,530 shares worth $24.1M.
  • Sarasin & Partners added most to International Flavors & Fragrances in Q2 2022, an estimated $174M increase.
  • Sarasin & Partners's biggest Q2 2022 reduction was JPMorgan Chase, cutting an estimated $104M.
  • Sarasin & Partners fully exited Marriott International in Q2 2022, selling an estimated $199M.
  • Sarasin & Partners's ten largest holdings make up 40% of its $7.93B portfolio in Q2 2022.
  • Sarasin & Partners opened 5 new positions and closed 5 in Q2 2022.
  • Sarasin & Partners's portfolio value fell 20% quarter-over-quarter to $7.93B.

Based on Sarasin & Partners's 13F filing for Q2 2022, filed 13 Jul 2022.